Table Of Content

AUTHOR INDEX TO VOLUME 62 Aasa R, 147 Mitchell PCH, 183 Aime S, 213 Mitra S, 271 Albertini R, 41 Molenda JJ, 127 Alzuet G, 31 Molnar J, 171 Ascenzi P, 213 Mondal MS, 271 Barros FJG, 57 Nelson MJ, 171 Bednarski PJ, 281 Nikoli¢ AT, 117 Borras J, 31 Oberleas D, 231 Branca M, 223 Paoletti S, 213 Brunori M, 77 Parker SF, 183 Calahorro CV, 57 Pinelli S, 41 Cameselle JC, 57 Rodriguez-Argiielles C, 41 Carvalho E, 147 Rolando FJH, 57 Casanova J, 31 Rolli G, 77 Casas JS, 41 Sanchez A, 41 Castifieiras A, 31 Saponja JA, 253 Charles BG, 1 Sau S, 223 Chen T-B, 117 Schinina ME, 77 Claros JCV, 57 Serves SV, 207 Coletta M, 213 Sievers C, 199 Cutruzzola F, 77 Silvestrini MC, 77 Desideri A, 213 Simkiss K, 183 Deters D, 199 Simmons J, 183 Djokic D, 17 Singh D, 67 Djurdjevic P, 17 Singh RV, 67 Duckworth PA, 1 Six S, 89 Fahrenholz F, 89 Sordo J, 41 Fasano M, 213 Stephanos JJ, 155 Fruianu M, 223 Sumalan SL, 31 Gahan LR, | Supuran CT, 31, 207 Gao F, 137 Tang W, 243 Garcia AB, 57 Tarricone C, 213 Garcia-Tasende MS, 41 Taylor MG, 183 Gasowska A, 103 Trageser M, 89 GGthe P-O, 147 Unden G, 89 Hambley TW, 1, 171 Vazquez-Lopez A, 41 Hanusa TP, 127 Viola F, 213 Hartmann H-J, 199 Voehler MW, 127 Hevér A, 171 Vogel HJ, 253 Ioannou PV, 207 Vuk-Pavlovic S, 117 Jha NK, 67 Wallis SC, 1 Jones MM, 127 Wang H, 137 Jurani¢ N, 117 Weser U, 199 Kidd SE, 171 Yang B, 137 Kéckerbauer R, 281 Yang P, 137 Kojro E, 89 Yue S, 243 Lomozik L, 103 Zhang B, 243 Lunghi P, 41 Zhong W, 243 Macura S, 117 Zhu L, 243 Maichle-Méssmer C, 41 Zoroddu MA, 223 Maras B, 77 PII S0162-0134(96)00072-4 SUBJECT INDEX TO VOLUME 62 A. alternata Copper(II)/adenosine triorganosilicon(IV) compounds and, 67 binding sites and complex stability, 103 A. niger Copper(II) complexes triorganosilicon(IV) compounds and, 67 fluoroquinolone antimicrobial ciprofloxacin, 1 Acetato(dimethy!)(pyridine-2- Copper(II)-mitoxantrone complex carbaldehydethi icarb »)tin(IV) acetic acid antitumor activity and DNA synthesis, 137 solvate, [SnMe,(PyTSC)(OAc)].HOAc Copper(!),-thionein synthesis, structure, and spectroscopic studies, 41 stable thiyl radicals and dried yeast, 199 N-Acetyicysteine Crab granules thiyl radicals formed from, 199 amorphous calcium phosphates, 183 Adenosine Cyanide copper(II)/adenosine binding to cytochrome c, 213 binding sites and complex stability, 103 Cysteine Amorphous calcium phosphates thiy! radicals formed from, 199 hydrated sites in biogenic, 183 Cytidine/putrescine systems Angiotensin I-converting enzyme binding sites and complex stability, 103 cobalt-substituted Zn-protein, 147 Cytochrome c Antibiotic resistance of bacteria ligand binding, 213 palladium(II) complexes of phenothiazines, 171 D, domain Antiplasmid activity on bacteria nitrate reductase palladium(Il) complexes of phenothiazines, 171 Pseudomonas aeruginosa, 77 Antitumor activity 3,5-Di-tert-butyl-1,2,-catechol ligands acetato(dimethyl)(pyridine-2- chromate anion reaction, 223 c y tin(IV) acetic acid Dichloro(o-phenylenediamine)platinum (II) complexes solvate, [SnMe,PyTSC)(OAc)].HOAc, 41 antitumor activity, 281 cisplatin analogs that bear o-phenylenediamine 2,3-Dihydroxypropylarsonic acids ligands, 281 isozyme II inhibition with arsonolipids and, 207 copper(II)-mitoxantrone complex, 137 1,2-Dimethyl-3-hydroxypyrid-4-one Arsonolipids strucutre, 127 isozyme II inhibition with 2,3-dihydroxypropylarsonic DNA synthesis acids and, 207 copper(II)-mitoxantrone complex, 137 Azide Drug-protein interactions, 155 binding to cytochrome c, 213 Escherichia coli Bacteria FNR and, 89 palladium(II) complexes of phenothiazines and anti- Ethylenediamine-NN,,N ’ N tetraacetic acid (EDTA) plasmid activity, 171 metallothionein reaction, 243 '3C NMR relaxation studies F. oxysporum gadolinium(III) complex, 127 triorganosilicon(IV) compounds and, 67 Cadmium(II) Fecal radioactivity interaction with fructose 2,6-bisphosphate and analogs, zinc homeostasis and, 231 57 Fluoride Caffeine binding to cytochrome c, 213 reactivity response of heme proteins, 155 Fluoroquinolone antimicrobial ciprofloxacin Calcium phosphates copper(II) complexes, | hydrated sites in biogenic amorphous, 183 FNR Calcium(Il) reactivity of N-terminal cysteine residues, 89 interaction with fructose 2,6-bisphosphate and analogs, Fructose 2,6-bisphosphate and analogs S7 divalent metal ion interaction, 57 Carbonic anhydrase Gadolinium(III) complex 8-quinolinsulfonamide(Hsa), 31 °C NMR relaxation studies, 127 Carbonic anhydrase inhibitors Glutathione isozyme II inhibition with 2,3-dihydroxypropylarsonic thiyl radicals formed from, 199 acids and arsonolipids, 207 Glycine 1,2-Catechol ligands tin(II) hydrolysis and complexation with, 17 chromate anion reaction, 223 Hemoglobin Chromate anion two-site binding of heterocyclic ligands, 155 reaction with 1,2-catechol or 3,5-di-tert-butyl-1,2,-cat- Heterocyclic ligands echol ligands, 223 two-site binding to monomeric hemoglobin, 155 Chromium(IlII) Homeostasis monoanionic complexes of 1,2-semiquinones, 223 zinc, 231 Ciprofloxacin Hydroxyapatite fluoroquinolone antimicrobial amorphous calcium phosphates and, 183 copper(II) complexes, | 5-Hydroxy-2-hydroxymethyl-1-methylpyrid-4-one struc- Cisplatin analogs ture, 127 o-phenylenediamine ligands and, 281 Imidazole Cobalt binding to cytochrome c, 213 xanthine oxidase activity inhibition, 271 Invertebrate cells Cobalt-substituted angiotensin I-converting enzyme amorphous calcium phosphates, 183 electron paramagnetic resonance studies, 147 Iron Cobalt(IIl) oligopeptide complexes metal-ion binding properties, 253 nitrogen-15 NMR, 117 PII S0162-0134(96)00073-6 302 SUBJECT INDEX Iron(II) Protein FNR interaction, 89 bivalent tin complexation, 17 Isozyme II inhibition Pseudomonas aeruginosa nitrate reductase 2,3-dihydroxypropylarsonic acids and arsonolipids, 207 isolation and characterization of d, domain, 77 Magnesium Purine xanthine oxidase activity inhibition, 271 reactivity response of heme proteins, 155 Magnesium(II) Putrescine interaction with fructose 2,6-bisphosphate and analogs, cytidine/putrescine systems 57 binding sites and complex stability, 103 N-2-mercaptopropionylglycine Pyridine thiyl radicals formed from, 199 binding to cytochrome c, 213 Mercaptosuccinic acid 8-Quinolinsulfonamide(Hsa) thiyl radicals formed from, 199 metal complexes, 31 Mercury S. viridans bacteria xanthine oxidase activity inhibition, 271 triorganosilicon(IV) compounds and, 67 Metal ions Silicon(IV) compound coordination bovine xanthine oxidase activity inhibition, 27) triorganosilicon(1V) compounds interaction with fructose 2,6-bisphosphate and analogs, synthesis, structural study, and biological activity, 67 57 Sodium dichromate metallothionein and metabolism, 243 reaction with 1,2-catechol or 3,5-di-tert-butyl-1,2,-cat- transferrins and binding properties, 253 echol ligands, 223 Metal( II)-8-quinolinsulfonamidato (sa’) Sulfur radical species complexes formation and stabilization, 199 synthesis and characterization, 31 Tetraglycinato ligand coordination, 117 Metallothionein Theophylline reaction with ethylenediamine-NN,, NV’N tetraacetic acid, reactivity response of heme proteins, 155 243 Thiyl radicals Mitoxantrone complex dried yeast copper(1),-thionein and stable, 199 antitumor activity and DNA synthesis, 137 Tin Nickel protein interactions with bivalent, 17 xanthine oxidase activity inhibition, 271 Tin(Il) Nitrate reductase d, domain hydrolysis and complexation with glycine, 17 Pseudomonas aeruginosa, 77 Tin(IV) Nitrogen-15 NMR acetato(dimethy])(pyridine-2- cobalt(III) oligopeptide compiexes, 117 carbaldehydethiosemicarbazonato)tin(IV) acetic acid N-Terminal cysteine residues solvate, [SnMe,(PyTSC)(OAc)].HOAc reactivity in FNR, 89 synthesis, structure, and spectroscopic studies, 41 Oligopeptide complexes Transferrins nitrogen-15 NMR and cobalt(III), 117 metal-ion binding properties, 253 P. mirabilis Triorganosilicon(IV) compounds triorganosilicon(IV) compounds and, 67 synthesis, structural study, and biological activity, 67 Palladium(Il) complexes of phenothiazines Vanadium-51 NMR study antiplasmid activity on bacteria, 171 metal-ion binding properties of transferrins, 253 Pancreas Xanthine oxidase activity inhibition zinc homeostasis and, 231 mercury and, 271 Penicillamine Zinc thiyl radicals formed from, 199 xanthine oxidase activity inhibition, 271 Phenothiazines Zinc homeostasis palladium(II) complexes mechanism, 231 antibiotic resistance of bacteria, 171 Zinc protein angiotensin I-converting enzyme o-Phenylenediamine ligands cobalt-substituted, 147 cisplatin analogs that bear, 281 Zinc (II) Platinum complexes interaction with fructose 2,6-bisphosphate and analogs, cisplatin analogs that bear o-phenylenediamine ligands, 57 281 synthesis and characterization, 31